Aberrant Cellular Differentiation and Migration in Renal and Pulmonary Tuberous Sclerosis Complex
- 1 September 2004
- journal article
- other
- Published by SAGE Publications in Journal of Child Neurology
- Vol. 19 (9) , 710-715
Abstract
This review is focused on pathways and mechanisms that might provide molecular links between the pathogenesis of renal and pulmonary disease in tuberous sclerosis complex and the pathogenesis of the neurologic manifestations of tuberous sclerosis complex. Tuberous sclerosis complex is an autosomal dominant disorder in which the manifestations can include seizures; mental retardation; autism; benign tumors of the brain, retina, skin, and kidneys; and pulmonary lymphangiomyomatosis. Lymphangiomyomatosis is a life-threatening lung disease affecting almost exclusively young women. Genetic data have demonstrated that the cells giving rise to renal angiomyolipomas, the most frequent tumor type in patients with tuberous sclerosis complex, exhibit differentiation plasticity. Genetic studies have also shown that the benign smooth muscle cells of angiomyolipomas and pulmonary lymphangiomyomatosis have the ability to migrate or metastasize to other organs. These findings indicate that hamartin and tuberin play functional roles in the regulation of cell migration and differentiation. The biochemical pathways responsible for these effects are not yet fully understood but might involve dysregulation of the small guanosine triphosphatase Rho. Similar pathways might contribute to aberrant neuronal differentiation and migration in tuberous sclerosis complex. (J Child Neurol 2004;19:710—715).Keywords
This publication has 63 references indexed in Scilit:
- Rheb is a direct target of the tuberous sclerosis tumour suppressor proteinsNature Cell Biology, 2003
- Rheb is an essential regulator of S6K in controlling cell growth in DrosophilaNature Cell Biology, 2003
- Markers of cellular proliferation are expressed in cortical tubersAnnals of Neurology, 2003
- Tuberin, the tuberous sclerosis complex 2 tumor suppressor gene product, regulates Rho activation, cell adhesion and migrationOncogene, 2002
- Mutation analysis of the TSC1 and TSC2 genes in Japanese patients with pulmonary lymphangioleiomyomatosisJournal of Human Genetics, 2002
- TSC2 missense mutations inhibit tuberin phosphorylation and prevent formation of the tuberin-hamartin complexHuman Molecular Genetics, 2001
- The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitinationOncogene, 2000
- High Frequency of Pulmonary Lymphangioleiomyomatosis in Women With Tuberous Sclerosis ComplexMayo Clinic Proceedings, 2000
- Mutational analysis of the tuberous sclerosis geneTSC2 in patients with pulmonary lymphangioleiomyomatosisJournal of Medical Genetics, 2000
- Identification of Tuberin, the Tuberous Sclerosis-2 Product. TUBERIN POSSESSES SPECIFIC Rap1GAP ACTIVITYJournal of Biological Chemistry, 1995